Gene Polymorphism of MUC15, MMP14, BRAF, and COL1A1 Is Associated with Capsule Formation in Hepatocellular Carcinoma

por Sun, Wei, Zhang, Yongchao, Liu, Bozhi, Duan, Youjia, Li, Wei, Chen, Jinglong
Publicado 2021

Associations Between Single Nucleotide Polymorphisms of Hypoxia-Related Genes and Capsule Formation in Hepatocellular Carcinoma

por Chen, Shanshan, Duan, Youjia, Zhang, Yongchao, Cheng, Long, Cai, Liang, Hou, Xiaopu, Li, Wei
Publicado 2023

Comparison of the Efficacy and Safety of Transarterial Chemoembolization Plus Microwave Ablation versus Surgical Resection in Patients with Solitary Large Hepatocellular Carcinoma:...

por Zhang, Yongchao, Chen, Hualei, Chen, Shanshan, Duan, Youjia, Cheng, Long, Gao, Jie, Li, Wei
Publicado 2022

The development of a predictive risk model on post-ablation hemobilia: a multicenter matched case–control study

por Liu, Bozhi, Li, Honglu, Guo, Jiang, Duan, Youjia, Li, Changqing, Chen, Jinglong, Zheng, Jiasheng, Li, Wei
Publicado 2021

Imaging features and outcomes in patients with ruptured hepatocellular carcinoma following transcatheter arterial chemoembolization: a retrospective clinical study

por Zhao, Wenpeng, Hou, Xiaopu, Li, Honglu, Guo, Jiang, Cai, Liang, Duan, Youjia, Du, Hongliu, Shao, Xihong, Diao, Zhenying, Li, Changqing
Publicado 2021

FAM83H-AS1/miR-485-5p/MEF2D axis facilitates proliferation, migration and invasion of hepatocellular carcinoma cells

por Zhao, Wenpeng, Guo, Jiang, Li, Honglu, Cai, Liang, Duan, Youjia, Hou, Xiaopu, Diao, Zhenying, Shao, Xihong, Du, Hongliu, Li, Changqing
Publicado 2021

Retraction Note: FAM83H-AS1/miR-485-5p/MEF2D axis facilitates proliferation, migration and invasion of hepatocellular carcinoma cells

por Zhao, Wenpeng, Guo, Jiang, Li, Honglu, Cai, Liang, Duan, Youjia, Hou, Xiaopu, Diao, Zhenying, Shao, Xihong, Du, Hongliu, Li, Changqing
Publicado 2022

Treatment efficacy and safety of drug-eluting beads transarterial chemoembolization versus conventional transarterial chemoembolization in hepatocellular carcinoma patients with ar...

por Cai, Liang, Li, Honglu, Guo, Jiang, Zhao, Wenpeng, Duan, Youjia, Hou, Xiaopu, Cheng, Long, Du, Hongliu, Shao, Xihong, Diao, Zhenying, Hao, Yiwei, Zheng, Xinmei, Li, Changqing, Li, Wei
Publicado 2022

A multi-center retrospective study on the efficacy and safety of regorafenib vs. regorafenib combined with PD-1 inhibitors as a second-line therapy in patients with advanced hepato...

por Yan, Tao, Huang, Chenyang, Peng, Caiyun, Duan, Xuezhang, Ji, Dong, Duan, Youjia, Zhang, Wen, Zhao, Haitao, Gao, Kun, Yang, Xiangyu, Zhang, Linzhi, Cheng, Jiamin, de Castria, Tiago Biachi, Pocha, Christine, Tsilimigras, Diamantis I., Wu, Tong, Su, Guodong, Li, Yinyin, Yu, Lingxiang, Lu, Yinying
Publicado 2023